Recursion's "Era of TechBio" Panel at JPM Featuring Dean Li, Kimberly Powell, Alex Gorsky & Tony Kim скачать в хорошем качестве

Recursion's "Era of TechBio" Panel at JPM Featuring Dean Li, Kimberly Powell, Alex Gorsky & Tony Kim

A panel featuring leaders across investment, tech, and industry discussed the "Era of TechBio" at Recursion's event at the San Francisco Mint during the 2025 J.P. Morgan Healthcare Conference. In a panel discussion led by Natasha Loder of The Economist, panelists answered the question – when it comes to TechBio, are we there yet? Dean Li, executive vice president and president of Merck Research Laboratories, said the “era of computational power will effect every industry,” and that TechBio “flavor” will be embedded throughout the pharma industry. Kimberly Powell, vice president of healthcare at NVIDIA, said not only is TechBio here, but it is creating a “paradigm shift” where we’ll now start discovery with AI “use the predictive power of models and then go into the wet lab [to validate], and take that data and put back in models - it’s a complete flip flop of how it’s been done.” Alex Gorsky, former CEO of Johnson & Johnson, said the question now is: “How does AI impact the entire system of bringing drugs to market?” Tony Kim, Managing Director at BlackRock, said he sees “promising signs” as a 27-year tech investor, adding that generative AI “has a superpower that could crack this vertical industry.”